Skip to main content

Table 1 Patient Characteristics for before SIPTW adjustment and after SIPTW adjustment

From: The outcome of intravenous and inhalation anesthesia after pancreatic cancer resection: a retrospective study

Varible

Before SIPTW adjustment

 

After SIPTW adjustment a

  

INHA

TIVA

P

INHA

TIVA

P

SMD b

    

Sum of weight

Sum of weight

  
 

n = 307

n = 114

 

 = 307.2

 = 113.6

  

Sex (%)

  

0.667

  

0.995

0.001

Female

131 (42.7)

52 (45.6)

 

133.9 (43.6)

49.6 (43.6)

  

Male

176 (57.3)

62 (54.4)

 

173.2 (56.4)

64.0 (56.4)

  

Age

57.00

57.00

0.430

57.00

57.00

0.772

0.018

(median-IQR, year)

[51.0,63.0]

[49.25, 62.00]

 

[51.0,62.0]

[50.00, 62.00]

  

BMI

23.44

22.86

0.305

23.41

23.04

0.898

0.066

(median-IQR, kg/m2)

[21.34,25.81]

[21.43,25.16]

 

[21.26,25.65]

[21.63,25.94]

  

Smoke(%)

  

0.538

  

0.995

0.001

No

171 (55.7)

68 (59.6)

 

175.1 (57.0)

64.8 (57.0)

  

Yes

136 (44.3)

46 (40.4)

 

132.1 (43.0)

48.8 (43.0)

  

Drink (%)

  

0.858

  

0.824

0.024

No

236 (76.9)

86 (75.4)

 

235.9 (76.8)

88.4 (77.8)

  

Yes

71 (23.1)

28 (24.6)

 

71.3 (23.2)

25.2 (22.2)

  

Hypertension (%)

  

1.000

  

0.940

0.008

No

252 (82.1)

93 (81.6)

 

251.5 (81.9)

92.7 (81.6)

  

Yes

55 (17.9)

21 (18.4)

 

55.6 (18.1)

20.9 (18.4)

  

Diabetes (%)

  

0.760

  

0.858

0.019

No

264 (86.0)

96 (84.2)

 

263.0 (85.6)

98.0 (86.3)

  

Yes

43 (14.0)

18 (15.8)

 

44.1 (14.4)

15.6 (13.7)

  

Adjuvant treatment (%)

  

0.832

  

0.901

0.014

No

213 (69.4)

81 (71.1)

 

215.0 (70.0)

80.2 (70.6)

  

Yes

94 (30.6)

33 (28.9)

 

92.2 (30.0)

33.4 (29.4)

  

Blood transfusion (%)

  

0.355

  

0.861

0.020

No

185 (60.3)

75 (65.8)

 

189.4 (61.7)

68.9 (60.7)

  

Yes

122 (39.7)

39 (34.2)

 

117.7 (38.3)

44.6 (39.3)

  

Duration

4.00

4.00

0.956

4.00

4.00

0.520

0.019

(median-IQR, h)

[3.5, 4.5]

[3.5, 4.5]

 

[3.5, 4.5]

[3.5, 4.5]

  

ASA (%)

  

0.290

  

0.996

0.009

I

7 (2.3)

4 (3.5)

 

7.9 (2.6)

2.8 (2.5)

  

II

294 (95.8)

105 (92.1)

 

291.0 (94.8)

107.7 (94.8)

  

III

6(2.0)

5 (4.4)

 

8.2(2.7)

3.1(2.7)

  

Tumour location (%)

  

0.425

  

0.963

0.005

Head

224 (73.0)

78 (68.4)

 

220.0(71.6)

81.1(71.4)

  

Tail

83 (27.0)

36 (31.6)

 

87.2(28.4)

32.5(28.6)

  

TMN (%)

  

0.372

  

0.986

0.019

I

158 (51.5)

51 (44.7)

 

152.1 (49.5)

56.2 (49.5)

  

II

124 (40.4)

50 (43.9)

 

126.9 (41.3)

46.4 (40.8)

  

III

25 (8.1)

13 (11.4)

 

28.2 (9.2)

11.0 (9.7)

  

Surgery type (%)

  

0.660

  

0.999

0.005

Distal pancreatectomy

89 (29.0)

38 (33.3)

 

93.0 (30.3)

34.6 (30.5)

  

Pancreaticoduodenectomy

2 (0.7)

1 (0.9)

 

2.2 (0.7)

0.8 (0.7)

  

Other

216 (70.4)

75 (65.8)

 

212.0 (69.0)

78.1 (68.8)

  

Degree of differentiation(%)

  

1.000

  

0.806

0.027

Poor

115 (37.5)

43 (37.7)

 

114.3 (37.2)

40.8 (35.9)

  

Well

192 (62.5)

71 (62.3)

 

192.9 (62.8)

72.8 (64.1)

  
  1. Abbreviations: IQR Inter-quartile range; Cancer stages: stage I: T1, N0, M0/T2, N0, M0/T1, N1, M0; stage II: T3, N0, M0/T4a, N1, M0/T3, N1, M0/T2, N2, M0/T1, N3, M0; stage III: T2, N3, M0/T3, N2, M0/T3, N3, M0/T4a, N2, M0/T4a, N3, M0/any T4b, any N, M0; stage IV: any T, any N, M1.ASA American Society of Anesthesiologists, BMI Body mass index, INHA Inhalational anesthesia, TIVA Total intravenous anesthesia, SIPTW Stabilized inverse probability of treatment weighting, SMD Standardized Mean Difference
  2. Note:.a Because the weighted values were presented, the number of patients were not an integer
  3. b Confounding factors were adjusted, SMD < 0.1, P > 0.05
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us